Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

Tue, 06th Apr 2021 14:54

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

GlaxoSmithKline PLC - Brentford, Middlesex-based pharmaceutical firm - Hires Anne Beal as non-executive director, starting May 6. Beal will replace Lynn Elsenhans as chair of the Corporate Responsibility Committee, and Elsenhans will stay on the board for an additional year to allow for a handover. Beal is founder and chief executive officer of AbsoluteJOI Skincare. She spent six years at Harvard Medical School and Massachusetts General Hospital, instructing in paediatrics.

----------

Assura PLC - Warrington, England-based primary care property investor - Jenefer Greenwood will retire as non-executive director at Assura's July 6 annual general meeting. Hires Emma Cariaga, Noel Gordon and Sam Barrell as new non-executive directors, starting on May 1. Cariaga is joint head of Canada Water Development on the executive committee of British Land Co PLC. Gordon was global managing director at consultants Accenture. For the UK National Health Service, he was chair of NHS Digital and a non-executive director of NHS England. Barrell is chief operating officer of the Crick Institute, which supports biomedical research.

----------

Rosslyn Data Technologies PLC - London-based cloud enterprise data analytics platform - Chief Executive Officer Roger Bullen steps down from board, effective immediately, but will remain as an adviser for six months. Bullen served for five years as CEO and chief financial officer. Chief Customer Officer Paul Watts is promoted to CEO. Watts joined Rosslyn back in August and before that was CEO of Blue Prism KK Japan, a robotic process automation company. Both Chair James Appleby and CFO Ash Mehta will take on additional responsibilities. Rosslyn also says it expects its results for the financial year ending April 30 to be in line with market expectations. It will issue a trading update in late May.

----------

Celtic PLC - Glasgow football club - Confirms that Dominic McKay will join Celtic on April 19 before replacing retiring Peter Lawwell as chief executive on July 1. Scottish Rugby confirmed that McKay will leave as chief operating officer on April 16, following a successful handover. McKay, who also was chair of the Guinness Pro14 annual rugby union competition, will join the Celtic board.

----------

Amryt Pharma PLC - London-based biopharmaceutical firm focused on rare and orphan diseases - Hires Sheila Frame as president for the Americas. Frame has held senior positions at Novartis AG, Bristol-Myers Squibb Co and AstraZeneca PLC.

----------

MyHealthChecked PLC - Cardiff-based consumer home-testing healthcare - Peter Dines steps down as non-executive director on Tuesday. Dines is chief operating officer of Mercia Asset Management PLC, whose funds have a 28% stake in MyHealthChecked. He is standing down to focus on other portfolio companies.

----------

Northamber PLC - Chessington, Surrey-based audio-visual and information technology distributor - Promotes Finance Director Tony Lee to board and hires Riccardo Reggio as a non-executive director, both from last Thursday. Lee re-joined Northamber in August of last year, having previously been finance director from 2003 to 2005. Reggio is a corporate strategy and acquisitions adviser who worked at Monitor Group for 15 years.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Jun 2020 11:52

UK TRADING UPDATE SUMMARY: Integumen Kicks Off Covid-19 Skin Trials

UK TRADING UPDATE SUMMARY: Integumen Kicks Off Covid-19 Skin Trials

Read more
11 May 2020 12:19

Amryt Pharma Cheers Strong 2019 And Beats Expectations So Far In 2020

Amryt Pharma Cheers Strong 2019 And Beats Expectations So Far In 2020

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
23 Mar 2020 19:01

Amryt Pharma Financially Strong, Revenue Rises More Double Digits

Amryt Pharma Financially Strong, Revenue Rises More Double Digits

Read more
19 Dec 2019 14:13

Amryt Pharma Shares Rise As It Cheers Aegerion Acquisition Synergies

Amryt Pharma Shares Rise As It Cheers Aegerion Acquisition Synergies

Read more
5 Nov 2019 11:09

Amryt Pharma upbeat on progress in first nine months of year

(Sharecast News) - Amryt Pharma updated the market on its trading update for the nine months ended 30 September on Tuesday, noting that it had completed the transaction to acquire Aegerion Pharmaceuticals on 24 September.

Read more
5 Nov 2019 10:23

Amryt Pharma Revenue Rises On Performance From Two New Assets

Amryt Pharma Revenue Rises On Performance From Two New Assets

Read more
1 Oct 2019 18:49

Amryt Pharma Skin Condition Drug Gets US FDA Fast Track Designation

Amryt Pharma Skin Condition Drug Gets US FDA Fast Track Designation

Read more
1 Oct 2019 15:08

Amryt gets FDA fast track for Oleogel-S10

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced on Tuesday that the US Food and Drug Administration (FDA) has designated the investigation of 'AP101' - Oleogel-S10 - for the treatment of epidermolysis bullosa (EB) as a 'Fast Track' development programme.

Read more
30 Sep 2019 18:49

Amryt Pharma Loss Widens On Aegerion Deal Costs; Lojuxta Revenue Rises

Amryt Pharma Loss Widens On Aegerion Deal Costs; Lojuxta Revenue Rises

Read more
25 Sep 2019 12:24

Amryt Pharma Completes Combination With Aegerion Pharmaceuticals

Amryt Pharma Completes Combination With Aegerion Pharmaceuticals

Read more
24 Sep 2019 15:00

Amryt Pharma Shares Temporarily Suspended On Aegerion Buy

Amryt Pharma Shares Temporarily Suspended On Aegerion Buy

Read more
21 May 2019 12:35

Amryt Pharma Agrees To All-Paper Acquisition Of Aegerion (ALLISS)

LONDON (Alliance News) - Amryt Pharma PLC on Tuesday said it has agreed the all-paper acquisition of Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics Inc, and intends to raise USD60

Read more
17 Apr 2019 11:17

Amryt Pharma Loss Narrows On Revenue From Cholesterol Drug Lojuxta

LONDON (Alliance News) - Amryt Pharma PLC on Wednesday said its annual loss narrowed as a result of increased revenue from its drug Lojuxta.The company's pretax loss shrank to EUR25.7

Read more
28 Feb 2019 14:39

Amryt gets approval to extend EASE trial to infants and children

(Sharecast News) - Orphan drug company Amryt Pharma updated the market on its phase 3 'EASE' trial for AP101 as a potential treatment for epidermolysis bullosa (EB) on Thursday, reporting that following an assessment by the trial's independent data monitoring committee, it could now enrol infants and children with EB between the ages of 21 days to four years in the trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.